Hyperoxaluria
Information
- Disease name
- Hyperoxaluria
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT00199459 | Completed | Proteomic Study of Urinary Stone Disease | January 2005 | November 2008 | |
| NCT03095885 | Completed | N/A | A Pilot Study of Oxalate Absorption in Secondary Hyperoxaluria | November 2016 | March 2017 |
| NCT04119765 | Completed | Plasma Oxalate in Patient With Short Bowel | February 27, 2020 | May 4, 2022 | |
| NCT04571359 | Completed | Spot Urine Oxalate to Creatinine Ratio and 24 Hours Urinary Oxalate | February 1, 2019 | December 31, 2019 | |
| NCT04756024 | Completed | Reference Interval of Spot Urinary Oxalate to Creatinine Ratio in Children | June 1, 2018 | October 30, 2019 | |
| NCT00283387 | Completed | Phase 2 | Efficacy of Betaine for Reduction of Urine Oxalate in Patients With Type 1 Primary Hyperoxaluria | February 2007 | September 2011 |
| NCT00587041 | Completed | Phase 1/Phase 2 | Use of Oral Probiotics to Reduce Urinary Oxalate Excretion | February 2006 | July 2009 |
| NCT00588120 | Completed | Phase 1 | Enteric Oxalate Absorption Study in Unclassified Hyperoxaluria | December 1998 | January 2020 |
| NCT01127087 | Completed | Phase 1/Phase 2 | Oxazyme in Patients With Hyperoxaluria | May 2010 | October 2011 |
| NCT02038543 | Completed | Phase 1/Phase 2 | Hydroxyproline Influence on Oxalate Metabolism | September 2013 | January 2017 |
| NCT02289755 | Completed | Phase 2 | Evaluating ALLN-177 for Reducing Urinary Oxalate Excretion in Calcium Oxalate Kidney Stone Formers With Hyperoxaluria | September 2014 | February 2015 |
| NCT02404701 | Completed | N/A | Effect of Over-the-counter Dietary Supplements on Kidney Stone Risk | February 2015 | October 2016 |
| NCT02503345 | Completed | Phase 2 | Evaluate the Effect of ALLN-177 in Reducing Urinary Oxalate in Patients With Hyperoxaluria and Kidney Stones | July 2015 | January 2017 |
| NCT02547805 | Completed | Phase 2 | Evaluate the Effect of ALLN-177 in Reducing Urinary Oxalate in Patients With Secondary Hyperoxaluria and Kidney Stones Over 28 Days | September 2015 | January 2017 |
| NCT05443932 | Not yet recruiting | Phase 4 | Dapagliflozin and Hydrochlorothiazide in Recurring Kidney Stone Patients | March 4, 2024 | December 31, 2025 |
| NCT02780297 | Recruiting | Prospective Research Rare Kidney Stones (ProRKS) | May 2016 | July 2024 | |
| NCT00280215 | Withdrawn | Phase 3 | Renal Protective Effect of ACEI and ARB in Primary Hyperoxaluria | December 2007 | December 2011 |
| NCT06138327 | Withdrawn | Phase 1 | A Study of BMN 255 in Participants With Non-Alcoholic Fatty Liver Disease And Hyperoxaluria | September 26, 2023 | March 25, 2024 |
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0003159
- MeSH unique ID (MeSH (Medical Subject Headings))
- D006959